Historical Stock Price
ETFs Holding ABIO »    ABIO Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
11/14/2017 $1.20 $1.20 $1.15 $1.16 20.90K
11/15/2017 $1.15 $1.20 $1.15 $1.20 14.80K
11/16/2017 $1.30 $2.00 $1.30 $1.45 1.96M
11/17/2017 $1.40 $1.55 $1.35 $1.45 250.70K
11/20/2017 $1.50 $1.50 $1.40 $1.50 105.50K
ARCA biopharma is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases. Co.'s key product candidate, Gencaro™ (bucindolol hydrochloride), is a pharmacological beta-blocker and mild vasodilator that Co. is developing for the treatment of patients with atrial fibrillation, and chronic heart failure with reduced left ventricular ejection fraction. Co. also has pharmacogenetic and other patent rights to drug candidates that have potential indications in cardiovascular disease, oncology and other therapeutic areas, in both early and later stages of development.
ABIO historical stock prices picture
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on November 14, 2017, ABIO opened at $1.20, traded as high as $1.20 and as low as $1.15, and closed at $1.16. Trading volume was a total of 20.90K shares. On November 15, 2017, ABIO opened at $1.15, traded as high as $1.20 and as low as $1.15, and closed at $1.20. Trading volume was a total of 14.80K shares. On November 16, 2017, ABIO opened at $1.30, traded as high as $2.00 and as low as $1.30, and closed at $1.45. Trading volume was a total of 1.96M shares. On November 17, 2017, ABIO opened at $1.40, traded as high as $1.55 and as low as $1.35, and closed at $1.45. Trading volume was a total of 250.70K shares. On November 20, 2017, ABIO opened at $1.50, traded as high as $1.50 and as low as $1.40, and closed at $1.50. Trading volume was a total of 105.50K shares.

ABIO Historical Stock Prices By Date:

ABIO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/23/2007
End date: 11/20/2017
Start price/share: $1,100.40
End price/share: $1.50
Dividends collected/share: $0.00
Total return: -99.86%
Average Annual Total Return: -48.30%
Starting investment: $10,000.00
Ending investment: $13.64
Years: 10.00
Date Close
11/14/2017$1.16
11/15/2017$1.20
11/16/2017$1.45
11/17/2017$1.45
11/20/2017$1.50
ABIO is categorized under the Healthcare sector; below are some other companies in the same sector:

ABLX Historical Stock Prices
ABMD Historical Stock Prices
ABT Historical Stock Prices
ABUS Historical Stock Prices
ACAD Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACHV Historical Stock Prices
ACIU Historical Stock Prices

ABIO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.